Deutsche Bank analyst Justin Bowers initiates coverage on Abcam (NASDAQ:ABCM) with a Hold rating.
UPDATE: FDA CRL To Spectrum Pharmaceuticals Cited Deficiencies Related To Manufacturing And Indicated That A Reinspection Will Be Necessary
Spectrum Pharmaceuticals (NASDAQ:SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced receipt of a Complete Response Letter (CRL) from the U.S. Food and Drug Administration
